Reduced parasympathetic tone in newly diagnosed essential hypertension  by Goit, Rajesh Kumar & Ansari, Abdul Haque
Original Article
Reduced parasympathetic tone in newly diagnosed
essential hypertension
Rajesh Kumar Goit a,*, Abdul Haque Ansari b
aDepartment of Physiology, Nepalgunj Medical College, Banke, Nepal
bDepartment of Physiology, Birat Medical College, Biratnagar, Nepal
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 1 5 3 – 1 5 7
a r t i c l e i n f o
Article history:
Received 8 April 2015
Accepted 4 August 2015





a b s t r a c t
Aim: The aim of the study was to compare heart rate variability (HRV) of newly diagnosed
essential hypertensive subjects with controls.
Methods: The study was conducted on 120 hypertensive subjects and 120 controls.
Results: The time-domain measures, standard deviation of all RR intervals (SDNN), the
square root of the mean of the sum of the squares of differences between adjacent RR
intervals (RMSSD), and percentage of consecutive RR intervals that differ by more than 50 ms
(pNN50) which reﬂect parasympathetic activity were signiﬁcantly less in hypertensive
subjects. In frequency-domain measures, high frequency [HF (ms2)] and [HF (nu)], which
reﬂects parasympathetic activity, was signiﬁcantly less in hypertensive subjects while LF
(nu) and LF/HF (%), which reﬂect sympathetic activity, were comparable between the groups.
Conclusion: These ﬁndings suggest that HRV is reduced in subjects with newly diagnosed
essential hypertension and the parasympathetic dysregulation is present in the early stage
of essential hypertension.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Available online at www.sciencedirect.com
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Hypertension is deﬁned as a persistent elevated blood
pressure of ≥140/90 mmHg. Essential (primary) hypertension
is the most common type of hypertension, affecting 95% of all
cases of hypertension.1 Hypertension is the most important
preventable risk factor for premature death worldwide.2 It can
increase the risk of cerebral, cardiac, and renal events. Subtle
target-organ damage, such as left-ventricular hypertrophy,
microalbuminuria, and cognitive dysfunction, takes place
early in the course of hypertensive cardiovascular disease* Corresponding author. Tel.: +977 9841401135.
E-mail addresses: goit_rajesh@yahoo.com (R.K. Goit), ansari782000
http://dx.doi.org/10.1016/j.ihj.2015.08.003
0019-4832/# 2015 Cardiological Society of India. Published by Elsevierwhile catastrophic events, such as stroke, heart attack, renal
failure, and dementia, usually happen after long periods of
uncontrolled hypertension only.3 Thus, primary prevention of
hypertension may reduce the overall risk of cardiovascular
diseases.
Blood pressure is maintained physiologically by multiple
mechanisms such as neural, hormonal, and local controls.
Among them, neural control by autonomic nervous system
(ANS) is the most important regulatory mechanism of blood
pressure. Though hypertension is a multifactorial disease,
ANS dysfunction is an important factor in the development
and progression of hypertension.4@yahoo.com (A.H. Ansari).
 B.V. All rights reserved.
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heart rate around the mean value. A reduction in HRV is
associated with an increased risk of cardiac mortality and has
been shown to predict risk for cardiac events and overall
mortality.5 Studies have shown that changes in autonomic
regulation of the cardiovascular system tend to occur before
the manifestation of raised blood pressure.6 Therefore, HRV
analysis may provide important insights into the role of the
autonomic nervous system in the pathogenesis of essential
hypertension.7 The purpose of this study was to compare the
HRV of newly diagnosed essential hypertensive subjects with
control subjects.
2. Research design and methods
2.1. Subjects
The study consisted of two groups: subjects with newly
diagnosed hypertension and subjects without hypertension.
Two hundred and forty male and female subjects between the
age group of 30 and 50 years were recruited from the student
and staff population of Nepalgunj Medical College, Banke. One
hundred and twenty subjects with conﬁrmed stage 1 hyper-
tension (systolic pressure 140–159 and diastolic pressure 90–
99), who had never been treated with a hypertensive
medication for any indication, were the study group, and
healthy age- and sex-matched one hundred and twenty
normotensive subjects were the control group. The exclusion
criteria were diabetes, secondary hypertension, obese, known
history of chronic illness, and known neuropathy of any other
etiology. In case of smokers and alcohol users, the subjects
with the low nicotine and alcohol dependence were includ-
ed.8,9 The ethical clearance was obtained from the Ethics
Committee of the College. All participants gave their written
informed consent.
2.2. Clinical examination
All the subjects were subjected to clinical examination. Each
participant underwent the measurement of his weight and
height, recorded while wearing light indoor clothes but no
shoes. Using a measuring tape, waist circumference (midway
between the lower rib margin and the iliac crest) and hip
circumference (the maximal circumference over the buttocks)
were measured. Blood pressure was measured using standard
protocol.
2.3. Heart rate variability
The ECG signals for HRV were recorded using electrocardio-
graph (Maestros Magic R Series) after a supine rest for 15 min.
The resting ECG at spontaneous respiration was recorded for
ﬁve min in supine position at chart speed 100 mm/s. From ECG,
R-R intervals were measured manually with a ruler. Then
these R-R intervals were saved as ASCII ﬁle. This format was
readable by HRV analysis software 1.1 (Biomedical Signal
Analysis Group, Department of Applied Physics, University of
Kuopio, Finland). In this study, we analyzed HRV by three
methods: time-domain, frequency-domain, and Poincare plot.The time-domain analysis of HRV consisted of the standard
deviation of all RR intervals (SDNN), the square root of the
mean of the sum of the squares of differences between
adjacent RR intervals (RMSSD), and pNN50, which is the
percentage of consecutive RR intervals that differ by more than
50 milliseconds.7
The frequency-domain analysis of HRV consisted of the
power of high frequency (HF), (0.15–0.40 Hz); low frequency
(LF), (0.04–0.15 Hz); and very low frequency (VLF), (below
0.04 Hz) power ranges.7
It has been speculated that analysis of HRV based on the
methods of nonlinear dynamics might elicit valuable infor-
mation for the physiological interpretation of HRV. One
nonlinear method is Poincare plot. The Poincare plot is a
scatter plot of the current R-R interval plotted against the
preceding R-R interval. Using the method described by
Brennan,10 these plots were used to extract indexes, such as
length (SD2) and width (SD1) of the long and short axes of
Poincare plot images.
2.4. Statistical analysis
Different anthropometric and cardiorespiratory variables were
compared between the groups using Student independent t-
test and data are presented as mean  standard deviation.
However, nonparametric Mann–Whitney U test was applied
for comparisons of the HRV and the results are presented as
median (interquartile range). A p value of <0.05 was consid-
ered statistically signiﬁcant. Data were analyzed with statisti-
cal software IBM SPSS Statistics 21.
3. Results
3.1. Subject characteristics
Clinical characteristics of study participants are shown in
Table 1. There was no signiﬁcant difference between the
groups in terms of their age, body mass index (BMI), and waist
hip ratio. However, systolic blood pressure, diastolic blood
pressure, pulse rate, and respiratory rate were signiﬁcantly
higher in hypertensive subjects compared with normotensive
subjects.
3.2. Heart rate variability measures
3.2.1. Time-domain variables
The time-domain measures, SDNN, RMSSD, and pNN50 were
signiﬁcantly less in hypertensive subjects compared to normo-
tensive subjects. Hypertensive women had higher time-domain
measures compared to hypertensive men (Table 2).
3.2.2. Frequency-domain variables
The variables analyzed in frequency-domain measures in-
cluded power of LF, HF, in ms2 and normalized units (nu), and
ratio of LF to HF (LF/HF). The LF power (ms2), HF power (ms2),
and HF (nu) were signiﬁcantly less in hypertensive subjects
whereas LF (nu) and LF/HF ratio were comparable between the
groups. Hypertensive women had higher HF (ms2), HF (nu) and
lower LF (ms2) than hypertensive men (Table 3).
Table 4 – Poincare plot variables of hypertensive and normotensive subjects.
Male Female
HTN (78) NT (60) HTN (42) NT (60)
SD1 (ms) 11.4 (6.9–24.7) 26.2 (19.7–31.4)* 11.2 (6.9–24.1) 22.1 (17.5–29.8)*
SD2 (ms) 29.25 (17.7–37.5) 47.7 (34.4–56.3)* 46.8 (29.1–54.4) 52.1 (42.6–58.8)*
SD2/SD1 2.59 (1.14–3.04) 1.81 (1.22–2.27)* 4.71 (1.9–8.2) 1.91 (1.56–2.51)*
SD1, standard deviation perpendicular to line of entity in Poincare plot; SD2, standard deviation along the line of entity in Poincare plot. Results
are expressed as median (interquartile range).
* p < 0.05.
Table 1 – Anthropometric variables of hypertensive and normotensive subjects.
Variables Male Female
HTN (78) NT (60) HTN (42) NT (60)
Age, years 37.3  0.4 37.9  0.9 42.1  0.6 42.4  0.3
BMI, kg/m2 26.7  0.4 25.3  0.2 24.8  0.2 23.9  0.6
Waist hip ratio 0.86  0.02 0.84  0.12 0.81  0.17 0.82  0.24
SBP, mmHg 148  4.3 118  0.7* 142  4.6 112  0.8*
DBP, mmHg 94  6.5 72  0.5* 92  8.7 71  0.3*
Pulse rate 94.64  0.6 71.32  0.8* 86.22  0.7 73.11  0.2*
Respiratory rate 17.12  0.7 15.08  0.6* 18.32  0.8 16.41  0.7*
HTN, hypertensive; NT, normotensive; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. Results are expressed
as mean  SD.
* p < 0.05.
Table 2 – Time-domain variables of hypertensive and normotensive subjects.
Variables Male Female
HTN (78) NT (60) HTN (42) NT (60)
SDNN (ms) 22 (11–33) 33.5 (24–37)* 23 (12–34) 36 (30–40)*
RMSSD (ms) 14.7 (9.5–32.4) 30.7 (24.4–41.6)* 14.9 (9.8–32.7) 36.7 (27.6–43.7)*
pNN50 (%) 0.95 (0.00–5.5) 10 (3.4–24)* 0.96 (0.00–5.7) 16.4 (4.7–27.3)*
SDNN, standard deviation of all RR intervals; RMSSD, root mean square of differences of successive RR intervals; pNN50, percentage of
consecutive RR intervals that differ by more than 50 ms. Results are expressed as median (interquartile range).
* p < 0.05.
Table 3 – Frequency domain variables of hypertensive and normotensive subjects.
Variables Male Female
HTN (78) NT (60) HTN (42) NT (60)
LF (ms2) 32.5 (13–86) 131.5 (79–157)* 31.5 (13–85) 126 (86–235)*
LF (nu) 50 (36.6–57.3) 49.7 (40.6–69.4) 57.6 (42–71.8) 55 (39.2–66.9)
HF (ms2) 42.5 (11–127) 142.5 (69–188)* 163.5 (99–188) 182.5 (126–271)*
HF (nu) 46.1 (23.9–62.8) 59 (51.5–69.4)* 47 (23.9–63.4) 59.7 (50–73.9)*
LF/HF (%) 0.84 (0.58–1.41) 0.81 (0.58–1.15) 0.83 (0.58–1.40) 0.80 (0.56–.98)
LF, low frequency; HF, high frequency; nu, normalized unit. Results are expressed as median (interquartile range).
* p < 0.05.
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The variables analyzed in Poincare plot were SD1, SD2, and
ratio of SD2 to SD1 (SD2/SD1). Both the variables were
statistically less in hypertensive subjects (Table 4).
4. Discussion
The present study was designed to detect any alteration in
cardiac autonomic function in subjects with newly diagnosedessential hypertension. The ﬁndings indicate predictable
change in cardiac autonomic activity as measured by HRV.
Regular HRV test provides subclinical early detection of
autonomic neuropathy and thereby promotes timely diagnos-
tic and therapeutic intervention.11 Depressed levels of HRV
occur in a number of pathological conditions and predict
cardiovascular morbidity and mortality.12,13 In the present
study, all the time-domain measures were statistically low in
hypertensive subjects. The SDNN reﬂects total variability and
carries the strongest prognostic information in heart disease.7
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reﬂecting parasympathetic modulation.14 Thus, the time-
domain analysis of HRV showed decreased parasympathetic
activity in hypertensive subjects.
In frequency-domain measures, HF (ms2), LF (ms2), and HF
(nu) were signiﬁcantly low in hypertensive subjects; however,
LF (nu) and LF/HF were comparable between the groups. The
HF component of HRV is equivalent to spontaneous respirato-
ry sinus arrhythmia and is considered to represent the vagal
control of heart rate.15–17 The physiological explanation of VLF
alone is not well deﬁned.7 The LF seems to be jointly
contributed by both, vagal and sympathetic nerves.18 The
LF/HF is considered to reﬂect sympathovagal balance, and acts
as an indicator for the sympathetic nervous activity. The LF
(nu) is also considered as marker of sympathetic nervous
function.7 Thus, frequency-domain analysis of HRV indicates
that hypertensive subjects have decreased cardiac parasym-
pathetic activity but not the cardiac sympathetic activity.
The above differences between hypertensive and normo-
tensive subjects are in accordance with previous studies on
HRV regarding a small and nonsigniﬁcant increase in the LF
(nu) and the LF/HF in the hypertensive group.19 However,
Huikuri et al. displayed decreased LF/HF in the hypertensive
subjects.13 The subjects in the study by Huikuri et al. were
using vasoactive drugs at the time of the examination, which
may have inﬂuenced the results.
In both hypertensive and normotensive subjects, HF was
higher in women, which suggests a higher tonic parasympa-
thetic activity in women than in men. The observed difference
in heart rate dynamics between men and women could reﬂect
a protective role of estrogen in women. The compliance of the
brachial artery is higher in women than in men.20 Women
have greater HRV and greater complexity of heart rate
dynamics then men across a wide adult age spectrum.21 In
addition, hypertensive women have less cardiovascular
reactivity to stress compared with hypertensive men.22
In Poincare plot measures, SD1 and SD2 were signiﬁcantly
low in hypertensive subjects. Analysis of the SD2/SD1 ratio
provides information on the relationship between sympathet-
ic and parasympathetic tone. The present study showed a
higher ratio in subjects with hypertension. A higher SD2/SD1
ratio may reﬂect an increase in SD2, a decrease in SD1, or both.
A decrease in SD1 means a decrease in parasympathetic
activity while a decrease in SD2 means an increase in
sympathetic activity.23–25 In the present study, decrease in
SD1 was greater than in SD2, so a higher ratio implies both
reduced parasympathetic activity and greater sympathetic
activity in subjects with hypertension.
In most studies, HRV measures have been lower in
hypertensive subjects compared with normotensive sub-
jects.19,26–28 Investigators suggested that essential hyperten-
sion is commonly neurogenic and attributed to sympathetic
overdrive; the parasympathetic branch has largely been
neglected. In contrast to those studies, our study suggests
that ﬁrst parasympathetic withdrawal takes place in the early
stage of hypertension. This is conﬁrmed by decrease in all the
markers of parasympathetic system but by either signiﬁcant or
nonsigniﬁcant increase or decrease in the markers of
sympathetic system. Moreover, the results in essential
hypertension have been inconsistent showing changes inHF and LF in opposite directions. It might be because the
hypertensive subjects had never been treated with antihyper-
tensive medication. b-Blockers have been shown to increase
HF component while LF component of HRV has remained
unchanged or increased.28 This also conﬁrmed that a reduc-
tion in parasympathetic cardiac control signiﬁcantly contrib-
utes to a disturbance in cardiovascular control in subjects with
essential hypertension.
In clinical practice, it is not routine to assess sympatho-
vagal balance in those with diagnosed essential hypertension,
and there is no recommended clinical method on how to do so
in this circumstance. However, it may be appropriate to assess
HRV at an early stage in hypertension and identifying
cardiovascular autonomic failure at an early stage helps in
implementing appropriate interventions.
In conclusion, parasympathetic system is more involved
than the sympathetic system in subjects with newly diag-
nosed essential hypertension. The decreased parasympathetic
tone in hypertension is associated with increased sympathetic
tone. We also ﬁnd that women have relatively greater HRV
markers that are associated with parasympathetic activity
than men. This complementary ﬁnding indicates the impor-
tance of gender-related difference in heart rate dynamics.
Whether reduced HRV contributes to the increased cardiac
mortality in hypertension requires further study.
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